Clinical trials
Full profile accessFollow clinical development from trial design and recruitment through results.
- Trial phase
- Status
- Readouts
Company intelligence / Profile preview
Reckitt (formerly Reckitt Benckiser) is a global leader in consumer health, hygiene, and nutrition products, with a significant presence in Germany through its subsidiary Reckitt Benckiser Deutschland GmbH. The company's health portfolio includes well-known over-the-counter (OTC) brands such as Nurofen, Gaviscon, Strepsils, and Durex, focusing on pain relief, gastrointestinal health, and respiratory care. In Germany, the company operates extensive commercial and distribution networks, providing pharmaceutical solutions that bridge the gap between traditional medicine and consumer self-care. Reckitt's business model emphasizes innovation in delivery formats and fast-moving consumer healthcare goods to address common ailments and wellness needs.
Beyond the preview
Explore clinical development, deal activity, and the competitive landscape with Gosset’s full data platform.
Follow clinical development from trial design and recruitment through results.
Explore licensing agreements, acquisitions, and the assets behind each deal.
Trace financing activity and the investors behind a company’s development.
Compare peer pipelines by target, modality, and therapeutic area.
Explore technology platforms and the patent landscape around relevant assets.
Connect company news and source material to the questions you’re investigating.
See how Gosset can support your research on RPL Germany.